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Abstract
Introduction: Synovial macrophages, which can release proinflammatory factors, are responsible for the
upregulation of cartilage-breakdown proteases and play critical roles in cartilage degradation during the
progression of osteoarthritis (OA). In addition, shear stress exerts multifunctional effects on chondrocytes by
inducing the synthesis of catabolic or anabolic genes. However, the interplay of macrophages, chondrocytes, and
shear stress during the regulation of cartilage function remains poorly understood. We investigated the
mechanisms underlying the modulation of human chondrocyte urokinase plasminogen activator (uPA) expression
by macrophages and shear stress.
Methods: Human chondrocytes were stimulated by peripheral blood-macrophage- conditioned medium
(PB-MCM), or exposure of chondrocytes cultured in PB-MCM to different levels of shear stress (2 to 20 dyn/cm2).
Real-time polymerase chain reaction was used to analyze uPA gene expression. Inhibitors and small interfering RNA
were used to investigate the mechanism for the effects of PB-MCM and shear stress in chondrocytes.
Results: Stimulation of human chondrocytes with PB-MCM was found to induce uPA expression. We demonstrated
that activation of the JNK and Akt pathways and NF-B are critical for PB-MCM-induced uPA expression. Blocking
assays by using IL-1ra further demonstrated that IL-1b in PB-MCM is the major mediator of uPA expression in
chondrocytes. PB-MCM-treated chondrocytes subjected to a lower level of shear stress showed inhibition of MCM-
induced JNK and Akt phosphorylation, NF-B activation, and uPA expression. The PB-MCM-induced uPA expression
was suppressed by AMP-activated protein kinase (AMPK) agonist. The inhibitor or siRNA for AMPK abolished the
shear-mediated inhibition of uPA expression.
Conclusions: These data support the hypothesis that uPA upregulation stimulated by macrophages may play an
active role in the onset of OA and in the shear-stress protection against this induction.
Introduction
Osteoarthritis (OA) is the most common worldwide
articular disease and affects a large number of adults. It
results from articular cartilage failure induced by the
interactions of genetic, metabolic, biochemical, and bio-
mechanical factors with the secondary components of
inflammation [1]. The processes underlying OA involve
interactive degradation and repair systems in cartilage,
bone, and the synovium. It is also now believed that syno-
vial inflammation and the production of proinflammatory
or destructive mediators from the OA synovium are
important for the progression of OA [2]. Synovial tissues
from patients with early signs of OA show infiltrations of
macrophages that exhibit an activated phenotype and
produce proinflammatory cytokines, mainly interleukin
(IL)-1b and tumor necrosis factor (TNF)-a. Macrophage-
derived IL-1b and TNF-a are required for the release of
matrix metalloproteinases (MMPs) from the synovium
that will ultimately degrade cartilage tissues [3]. It also has
been observed that macrophages mediate osteophyte
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formation and fibrosis in the early stages of experimentally
induced OA [4]. However, the effects of macrophages on
human chondrocyte catabolic gene expression remain
unclear.
Cartilage is a flexible connective tissue consisting of
chondrocytes and an extracellular matrix (ECM). The
cartilage-specific ECM is a dynamic and complex network
consisting of water, collagen, and proteoglycan MMPs,
and other small molecules, and it plays an essential role in
cartilage structure and function [5]. In the processes that
involve the proteolytic degradation of cartilage, the plasmi-
nogen activator (PA) system has been suggested as playing
a key role in ECM remodeling [6]. This system is com-
posed of urokinase-type PA (uPA), tissue-type PA (tPA),
uPA receptor (uPAR), and PA inhibitor-1 (PAI-1). uPA is
a 55-kDa serine protease, which is released as an inactive
single-chain zymogen (pro-uPA). When bound to its
receptor, uPAR, pro-uPA is activated and converts plasmi-
nogen into plasmin [7]. It has been reported that uPA
can be upregulated in synovial fibroblasts from both OA
and rheumatoid arthritis samples [8]. However, the
molecular mechanisms underlying uPA expression in
human chondrocytes remain unknown.
OA can result from mechanical injury to articular carti-
lage. Chondrocytes in cartilage tissue are constantly
exposed to a variety of different mechanical forces that
modulate gene expression and metabolic activity in these
cells [9]. Previous studies have revealed that chondro-
cytes of the articular cartilage are exposed to different
levels of fluid flow [10,11], suggesting that mechanical
shear stress may be of pathophysiologic relevance in
cartilage biology. In addition, the development of chon-
drocyte/cartilage tissue-engineering constructs is affected
by different shear-stress ranges, revealing that fluid shear
stress may alter the intercellular signaling pathways
in chondrocytes [12,13]. Our previous study also indi-
cated that shear stresses at 5 and 10 dyn/cm2 (1 dyn =
10 μN) play an important role in the regulation of PAI-1
expression in human OA nonlesioned, but not lesioned,
chondrocytes [14]. These data indicate that the nature
and magnitude of shear stress may play a significant role
in the homeostasis of the structure and function of
cartilage.
The mechanical loading and inflammation in the joint
that cause cartilage breakdown are believed to be impor-
tant factors in the progression of OA. However, the
mechanisms underlying macrophage-induced uPA
expression in human chondrocytes, and the role of shear
stress in the modulation of macrophage-induced gene
expression, are still not understood. In our present study,
we investigated the interplay between shear stress and
inflammatory stimulation in modulating chondrocyte
catabolic gene expression by analyzing the effects of
shear stress on peripheral blood-macrophage-conditioned
medium (PB-MCM)-induced uPA expression in human
chondrocytes. In addition, PB-MCM-induced uPA expres-
sion was modulated by AMP-activated protein kinase
(AMPK): an AMPK agonist suppressed PB-MCM-induced
uPA expression, and inhibition of AMPK attenuated shear
stress-inhibition of uPA expression. These findings con-
cerning the mechanisms of suppression of PB-MCM-
induced responses in chondrocytes by shear stress provide
new insights into the pathophysiology of OA.
Materials and methods
Reagents
All culture materials were purchased from Gibco (Grand
Island, NY, USA). PD98059 (ERK inhibitor), SP600125
(JNK inhibitor), SB203580 (p38 inhibitor), LY294002
(PI3K/Akt inhibitor), IL1ra (IL-1-receptor antagonist),
tanshinone IIA (AP-1 inhibitor), 5-aminoimidazole-4-
carboxamide 1-b-D-ribonucleoside (AICAR, the AMPK
activator), and compound C (AMPK inhibitor) were pur-
chased from Calbiochem (La Jolla, CA, USA). Mouse
monoclonal antibodies (mABs) against JNK and phospho-
JNK were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Rabbit polyclonal antibodies
against Akt and mAB against phospho-Akt were pur-
chased from Cell Signaling Technology (Beverly, MA,
USA). Neutralizing mABs against TNF-a were purchased
from R&D Systems (Minneapolis, MN, USA). Human
uPA enzyme-linked immunosorbent assay (ELISA) kits
were obtained from American Diagnostica (Greenwich,
CT, USA). ERK, JNK, p38, and AMPK siRNA vectors, and
a control siRNA construct (containing random DNA
sequences) were purchased from Invitrogen (Carlsbad,
CA, USA). SN50 (NF-B inhibitor) was obtained from
Biomol Research Laboratories (Plymouth Meeting, PA,
USA). All other chemicals of reagent grade were obtained
from Sigma (St. Louis, MO, USA).
Culture of human chondrocytes
Normal human chondrocytes were purchased from Pro-
moCell (Heidelberg, Germany). Cells were grown in
complete chondrocyte growth medium supplemented
with 10% FBS. Cells at passage 2 or 3 were tested to
ensure that they expressed collagen type II before use in
the experiments. After reaching 80% confluency, the cells
were trypsinized and seeded onto glass slides.
Isolation of peripheral blood monocytes
Human monocytes from the buffy coat (Tainan Blood
Center, TBSF, Taiwan) were isolated as previously
described [15]. In brief, peripheral blood mononuclear
cells (PBMCs) were isolated with Histopaque 1077
density-gradient centrifugation. Monocytes were then
Yeh et al. Arthritis Research & Therapy 2013, 15:R53
http://arthritis-research.com/content/15/2/R53
Page 2 of 13
purified from PBMCs by negative selection by using a
magnetic-activated cell sorting (MACS) monocyte isola-
tion kit (Miltenyi Biotech, Auburn, CA, USA).
Preparation of peripheral blood monocyte-derived
macrophage-conditioned medium (PB-MCM)
Peripheral blood monocyte-derived macrophages were
counted and plated at 5 × 105 cells/well on cell-culture
dishes. For the collection of PB-MCMs for the culturing of
peripheral blood monocyte-derived macrophages, freshly
isolated peripheral blood monocytes were plated in 10%
FBS. After 5 days in culture, the monocyte-derived macro-
phages were incubated for a further 48 hours in fresh
serum-free RPMI medium. The conditioned media were
then collected and defined as PB-MCM.
Shear-stress experiment
Glass slides onto which cultured chondrocytes were
mounted in a parallel-plate flow chamber were previously
characterized and described in detail [16,17]. The chamber
was connected to a perfusion loop system and maintained
at 37°C in a temperature-controlled enclosure. The perfu-
sate was maintained at pH 7.4 by continuous gassing with
a humidified mixture of 5% CO2 in air. The fluid shear
stress (τ) generated on the cells by flow was estimated to be
2 to 20 dyn/cm2 by using the formula τ = 6 μQ/wh2, where
μ is the dynamic viscosity of the perfusate,Q is the flow rate,
and h andw are the channel height and width, respectively.
Real-time quantitative PCR
Total RNA preparations and RT reactions were carried
out as described previously [14]. Gene expression was
analyzed by quantitative real-time PCR (ABI Prism
7900HT) by using the SYBR Green PCR Master Mix
(Applied Biosystems). The primers used were as follows:
uPA forward, 5’-GCTCA CCACA ACGAC ATTGC-3’;
uPA reverse, 5’-CACCT GCCCT CCTTG GAA-3’; and
18S rRNA forward, 5’-CGGCG ACGAC CCATT
CGAAC-3’, 18S rRNA reverse, 5’-GAATC GAACC
CTGAT TCCCC GTC-3’. Values were normalized to
the levels of 18S rRNA. All primer pairs had at least one
primer that crossed an exon-exon boundary. Real-time
PCR reactions were performed in triplicate and quantified
by using the 2−ΔΔCt method.
Quantification of uPA expression
Release of uPA into culture media was analyzed by using
commercially available ELISA kits purchased from Ameri-
can Diagnostica, Inc. The assays and data calculations were
performed according to the manufacturer’s instructions.
Western blot analysis
Cells were lysed with a buffer containing 1% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS, and a protease inhibitor
mixture (containing PMSF, aprotinin, and sodium ortho-
vanadate). The total cell lysate (50 μg of protein) was
separated with SDS-polyacrylamide gel electrophoresis
(PAGE) (12% running, 4% stacking) and analyzed by
using the designated antibodies and the Western-Light
chemiluminescent detection system (Bio-Rad, Hercules,
CA), as previously described [18].
Reporter gene constructs, siRNA, transfection, and
luciferase assays
The dominant-negativemutant of Akt (DN-Akt) was kindly
provided by Dr. Yi-Shuan Li (University of California,
San Diego). Human uPA promoter constructs contain-
ing the -2,350/+30, -1,872/+30, -1,700/+30, and -670/
+30 5’-flanking regions of uPA were linked to the firefly
luciferase reporter gene in the pGL4 vector (Promega,
Madison, WI, USA), as previously reported [19]. uPA
promoter fragments containing mutations in the NF-B
binding sites (GG to TT) were produced by site-directed
mutagenesis. DNA plasmids at a concentration of 1 mg/
ml were transfected into cells by using Lipofectamine
(Gibco). The pSV-b-galactosidase plasmid was cotrans-
fected to normalize for the transfection efficiency.
For siRNA transfection, cells were transfected with the
designated construct by using a RNAiMAX transfection
kit (Invitrogen). ERK-, JNK-, and p38-siRNA transfections
caused at least an 80% reduction in the respective protein-
expression levels compared with the siRNA control vector.
Chromatin immunoprecipitation assay (ChIP)
ChIP assays were performed by using assay kits from
Santa Cruz Biotechnology. Cells were fixed with 1% for-
maldehyde for 10 minutes, washed, and then harvested
in SDS lysis buffer. After sonication, lysates containing
soluble chromatin were immunoprecipitated by using 2
μg of antibodies against IgG or NF-B p65. DNA was
purified with a PCR Purification Kit (Qiagen) and used
for PCR analysis. The amplified DNA fragments were
visualized on an agarose gel. Primers that amplify regions
of the human uPA promoter that contain the NF-B bind-
ing sites (-1,859/-1,707) were used as follows: 5’-CCTGA
TAACT AACCT GGGAG TTTC-3’ and 5’-CTTCA
GAGCC AACCT TGCTA CTTC-3’.
Transcription factor ELISA assay
Nuclear extracts were prepared as previously described
[19] and used for quantitative measurements of NF-B
p65 activation by using a commercially available ELISA
kit (Panomics, Redwood City, CA, USA).
Statistical analysis
The results shown in this study are expressed as mean ±
standard error of the mean (SEM). Statistical analysis
was performed by using an independent Student t test
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for two groups of data and analysis of variance (ANOVA)
followed by the Scheffé test for multiple comparisons.
P values of less than 0.05 were considered significant.
Results
Conditioned medium from macrophages induces the
upregulation of uPA in human chondrocytes
The effects of macrophages on the expression of uPA in
human chondrocytes were evaluated under PB-MCM
stimulation. Figure 1A shows the dose-dependent induc-
tion of uPA transcripts by PB-MCM in human chondro-
cytes. The time courses determined for the uPA mRNA
levels revealed an increase after 30 minutes of PB-MCM
stimulation and a peak expression at 2 hours, followed
by a gradual reduction thereafter (Figure 1B). The expo-
sure of chondrocytes to PB-MCM caused significant
increases in the uPA secretion levels from human chon-
drocytes (Figure 1C).
PB-MCM-induced uPA expression is mediated by the JNK
and Akt signaling pathways
The MAPK superfamily and PI3K/Akt pathways are
known to regulate gene expression and specific cellular
functions [20,21]. To determine whether PB-MCM-
induced uPA expression is mediated through the
MAPK- or PI3K/Akt-dependent pathways, human chon-
drocytes were exposed to specific inhibitors of ERK
(PD98059; 30 μM), JNK (SP600125; 20 μM), p38
(SB203580; 10 μM), or PI3K (LY294002, 30 μM) for
1 hour before and during stimulation with PB-MCM.
The PB-MCM-induced uPA mRNA expression in chon-
drocytes (Figure 2A) was significantly inhibited by
SP600125 and LY294002, but not by PD98059 and
SB203580. Treatment of chondrocytes with a combination
of SP600125 and LY294002 resulted in the additive inhibi-
tion of PB-MCM-induced uPA expression. To confirm
further the involvement of JNK and Akt, but not ERK and
p38, in the modulation of uPA expression by PB-MCM
stimulation, we examined the effects of expressing specific
MAPK siRNAs, and a DN-Akt plasmid on PB-MCM-
induced uPA expression in chondrocytes. PB-MCM-
induced uPA mRNA expression (Figure 2B) was inhibited
by JNK-specific siRNA and DN-Akt, but not by ERK-,
p38-, or control siRNAs (100 μmol/ml for each), or the
pcDNA3 empty vector. The phosphorylation of JNK
(Figure 2C) and Akt (Figure 2D) in chondrocytes increased
rapidly after PB-MCM stimulation, reaching maximal
levels at 10 minutes. After such transient increases, the
levels of phosphorylation decreased to nearly basal levels.
NF-B binding sites are major determinants of the PB-
MCM-induction of uPA promoter activity
The human uPA gene promoter contains multiple tran-
scription factor binding sites, including those for AP-1
and nuclear factor (NF)-B [22]. To elucidate the cis-
acting elements in the uPA gene promoter that mediate
PB-MCM-induced uPA transcription, luciferase assays
were conducted by using the p2350-Luc plasmid and
several deletion or mutant promoter constructs (Figure
3A). In human chondrocytes, the -2,350/+30 region of
the uPA promoter directed maximal luciferase activity.
Sequence deletions from -2,350 to -1,872 (which incor-
porate AP-1 binding sites) slightly impaired PB-MCM-
induced uPA promoter activity (about 20% lower than
the p2350-Luc). Further deletions from -1,872 to -1,700
(NF-B binding sites) and mutations in NF-B binding
sites, however, reduced PB-MCM-induced uPA promoter
activity by more than 80% (Figure 3A) compared with
p2350-Luc. We further tested whether NF-B and AP-1
activations are involved in the signal-transduction path-
way leading to PB-MCM-induced uPA gene expression.
Human chondrocytes were incubated with a specific
Figure 1 Induction of urokinase-type PA (uPA) in chondrocytes by peripheral blood-macrophage-conditioned medium (PB-MCM)
stimulation. Chondrocytes were maintained as controls (CL) or stimulated with PB-MCM. Data are the mean ± SEM. *P < 0.05 versus CL
chondrocytes. (A) The dose-dependent induction of uPA mRNA expression by PB-MCM. Human chondrocytes were grown as CL or were
stimulated with different concentrations of PB-MCM for 2 hours. (B) RNA samples were isolated from human chondrocytes at the indicated
times and subjected to real-time PCR analysis. The mRNA data are presented as the fold changes in fluorescent density from CL cells normalized
to the 18S rRNA levels. (C) uPA protein secretion in chondrocytes was determined by sandwich ELISA.
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inhibitor for NF-B (SN50, 100 and 200 nM) or AP-1
(Tanshinone IIA, 3 and 6 μM) for 1 hour, which was
followed by stimulation with PB-MCM for 2 hours. The
PB-MCM-induced uPA mRNA expression levels and
uPA promoter activity in chondrocytes (Figure 3B) was
significantly reduced through inhibition with SN50, and
partially inhibited with Tanshinone IIA, indicating that
NF-B is the major transcription factor involved in the
regulation of uPA gene induction.
To investigate whether NF-B binds the uPA promoter
region in human chondrocytes, we performed quantitative
analysis of the NF-B p65 binding activity in vitro by
using TF ELISA kits from Panomics. The treatment of
chondrocytes with PB-MCM caused increased NF-B
p65-DNA binding activity after 0.5 hours, which
remained elevated for at least 1 hour (Figure 3C). These
results were confirmed by ChIP analysis. Chromosomal
DNA immunoprecipitated with a p65 antibody was sub-
jected to PCR by using primers designed to amplify the
uPA promoter region harboring the NF-B binding site.
NF-B was indeed found to bind to the uPA promoter
region containing the NF-B consensus sites (Figure 3D).
Figure 2 The JNK and Akt pathways are required for peripheral blood-macrophage-conditioned medium (PB-MCM)-induced
urokinase-type PA (uPA) expression. Cells were untreated (CL) or stimulated with PB-MCM for 2 hours. The results shown are the mean ±
SEM from three to four independent experiments. Before culturing as CL or PB-MCM-stimulated cells, chondrocytes were pretreated with
PD98059 (PD; 30 μM), SP600125 (SP; 20 μM), SB203580 (SB; 10 μM), or LY294002 (LY, 30 μM) individually or in combination for 1 hour (A), or
transfected with control siRNA (si-CL), control pcDNA3 vector (vec), or siRNAs targeting ERK (si-ERK), JNK (si-JNK), p38 (si-p38), or dominant
negative mutant of Akt (DN-Akt) (B). *P < 0.05 versus CL. #P < 0.05 versus DMSO-treated, control siRNA (si-CL)-, or control pcDNA3 vector (vec)-
transfected cells under PB-MCM stimulation. **P < 0.05 versus SP- or LY-pretreated cells under PB-MCM stimulation. (C, D) Control (CL) or PB-
MCM-stimulated chondrocytes were maintained for the times indicated. The phosphorylation of JNK (C) and Akt (D) in these cells is indicated by
the band densities (normalized to total protein levels) relative to CL. *P < 0.05 versus CL cells.
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The JNK and Akt signaling pathways are involved in
macrophage-induced uPA promoter activity
To evaluate whether the inhibition of uPA expression by
the JNK and Akt signaling pathways occurs at the tran-
scriptional level, we studied the effects of specific inhibi-
tors, siRNA molecules that target JNK, and a DN-Akt on
PB-MCM-induced uPA p2350-Luc promoter (Figure 4A)
and NF-B p65 (Figure 4B) activities. Culturing of the
chondrocytes in PB-MCM increased the p2350-Luc and
NF-B p65 activities by 5.5- and 4.5-fold, respectively,
compared with unstimulated cells and after normalization
with a transfection control. Pretreatment of the cells with
SP600125 and LY294002, or transfection with JNK-siRNA
and DN-Akt, resulted in a marked inhibition of both the
PB-MCM-induced uPA promoter activity (Figure 4A) and
NF-B p65 activation (Figure 4B). Pretreatment with
SP600125 and LY294002 caused a simultaneous and
additive inhibition of PB-MCM-induced p2350-Luc and
NF-B p65 activities.
ChIP analysis further revealed that the pretreatment of
human chondrocytes with SP600125 and LY294002
inhibits the PB-MCM induction of NK-B p65 promoter
binding activity (Figure 4C). The combined treatment of
chondrocytes with SP600125 and LY294002 resulted in
the additive inhibition of PB-MCM-induced p65 promoter
binding activity (Figure 4C).
IL-1ra inhibits macrophage-induced signaling
transduction and uPA expression
IL-1b and TNF-a are major secreted products of macro-
phages [3]. The incubation of human chondrocytes with
IL-1-receptor antagonists (IL-1ra, 1 and 2 μg/ml), but not
TNF-a neutralizing antibody (20 and 40 μg/ml), signifi-
cantly inhibited PB-MCM-induced uPA mRNA expression
Figure 3 The role of nuclear factor (NF)-B in peripheral blood-macrophage-conditioned medium (PB-MCM)-induced urokinase-type
PA (uPA) mRNA expression and promoter activity. (A) Left panel, uPA promoter p2350-Luc plasmid, deletion, and mutant promoter
constructs. Right panel, PromoCell HCs were cotransfected with uPA promoter constructs and stimulated with PB-MCM for 2 hours. Promoter
activities were measured by using a luciferase assay normalized to b-galactosidase activity. They are shown relative to the activities in cells
transfected with p2350-Luc (set to 100%). *P < 0.05 versus p2350-Luc. #P < 0.01 versus p2350-Luc. (B) uPA mRNA and uPA p2350-Luc activity in
chondrocytes wase determined in cells pretreated with vehicle (DMSO), different doses of NF-kB inhibitor SN50, or AP-1 inhibitor Tanshinone IIA
(TIIA), and then stimulated with PB-MCM for 2 hours. *P < 0.05 versus CL. #P < 0.01 versus DMSO control with PB-MCM stimulation. **P < 0.05
versus DMSO control with PB-MCM stimulation. (C) NF-B p65 activation determined with TF ELISA. All bar graphs are indicative of fold-changes
compared with control chondrocytes (CL). *P < 0.05 versus CL. (D) ChIP analysis of NF-B by using a p65 antibody.
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(Figure 5A). Human chondrocytes directly stimulated with
TNF-a had minor effects on the expression of uPA and tPA
(Figure 5B). However, stimulation of chondrocytes with
IL-1b had similar effects on uPA expression to PB-MCM
(Figure 5B). The phosphorylation of JNK and Akt was simul-
taneously eliminated by pretreating the human chondrocytes
with IL-1ra (Figure 6A), which also inhibited PB-MCM-
induced NF-B promoter binding activity (Figure 6B).
Exposure of human chondrocytes to shear stress of 2 and
5 dyn/cm2 inhibits macrophage-induced uPA expression
Stimulation of human chondrocytes with PB-MCM
under static conditions increases uPA expression (Figure
7A). Exposure of chondrocytes cultured in PB-MCM to
shear stress at 2 and 5 dyn/cm2 was found to signifi-
cantly inhibit PB-MCM-induced uPA mRNA expression.
However, shear stresses at higher levels of 10 and 20
dyn/cm2 did not have such inhibitory effects (Figure
7A). Exposure of chondrocytes to shear stresses of 2
and 5 dyn/cm2, but not 10 and 20 dyn/cm2, resulted in
a marked inhibition of the PB-MCM-induced JNK and
Akt phosphorylation (Figure 7B), and also of p65
NF-B-DNA binding activity (Figure 7C).
Effect of AMPK on PB-MCM-induced uPA expression
A recent study showed that AMPK plays an important
role in regulating cell function and inflammation
in chondrocytes [23]. We investigated whether the
Figure 4 The JNK and Akt signaling pathways are involved in peripheral blood-macrophage-conditioned medium (PB-MCM)-induced
urokinase-type PA (uPA) promoter activity. Chondrocytes were maintained as controls (CL) or pretreated with vehicle (DMSO), with SP600125
(SP) and LY294002 (LY) individually or in combination for 1 hour, or transfected with control siRNA (si-CL), control pcDNA3 vector (vec), JNK-
siRNA (si-JNK), or DN-Akt plasmid, and then stimulated with PB-MCM. (A) uPA-2350-Luc activity was determined with luciferase assay after
stimulation with PB-MCM for 2 hours. (B) NF-B p65 activation was determined by TF ELISA after stimulation with PB-MCM for 1 hour. (C) NF-B
p65 binding to uPA promoter in chondrocytes after 1 hour PB-MCM stimulation was analyzed with ChIP assay. Cells were pretreated with vehicle
(DMSO), or with SP600125 (SP) and LY294002 (LY) individually or in combination for 1 hour. The ChIP assay was performed by using p65
antibody. All bar graphs indicate the fold changes compared with CL chondrocytes, mean ± SEM. *P < 0.05 versus CL. #P < 0.05 versus DMSO
control, si-CL, or vec-transfected cells with PB-MCM stimulation. **P < 0.05 versus SP- or LY-pretreated cells under PB-MCM stimulation.
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PB-MCM-induced uPA expression is modulated by
AMPK. Chondrocytes were incubated with different
doses of AMPK activator AICAR for 2 hours before and
during stimulation with PB-MCM. The PB-MCM-induced
mRNA expression of chondrocyte uPA was significantly
inhibited by 0.5 to 1 mM AICAR treatment (Figure 8A).
Conversely, the addition of 10 mM compound C or the
transfection of AMPK siRNA before exposure to shear
stress at 2 dyn/cm2 abolished the shear-mediated inhibi-
tion of uPA expression (Figure 8B). These results indicated
that AMPK plays an important role in the PB-MCM-
induction and shear-inhibition of uPA expression in
chondrocytes.
Discussion
Increasing evidence suggests that catabolic genes in
chondrocytes play an important role in the onset of OA
in cartilage [1]. Previous studies also demonstrated a
pivotal role for shear stress in regulating gene expres-
sion and function in chondrocytes [14,16,24-26]. The
novel findings of our present study are as follows:
1. Conditioned medium from peripheral blood macro-
phages increases uPA expression in human
chondrocytes;
2. This increase in uPA expression is particularly attri-
butable to the paracrine effects of the cytokine IL-1b
released by macrophages;
Figure 5 Interleukin (IL)-1b is the major factor underlying peripheral blood-macrophage-conditioned medium (PB-MCM)-induced
urokinase-type PA (uPA) expression in chondrocytes. RNA samples were then isolated and subjected to real-time PCR analysis. The mRNA
data are presented as the fold changes in fluorescent intensities compared with control (CL) chondrocytes normalized to the 18S rRNA levels.
(A) Chondrocytes were untreated (CL) or stimulated with PB-MCM for 2 hours. Before culturing under control conditions (CL) or stimulation with
PB-MCM, the PB-MCM and chondrocytes were preincubated with PBS, IL-1ra, isotype-matched IgG, or neutralizing antibody against TNF-a (TNF
Ab) individually for 2 hours. *P < 0.05 versus CL. #P < 0.05 versus PBS, IgG-, or TNF Ab-treated cells under PB-MCM stimulation. (B) Chondrocytes
cultured as unstimulated CL, or stimulated with different doses of IL-1b or TNF-a for 2 hours. *P < 0.01 versus CL.
Figure 6 Effects of interleukin (IL)-1ra on peripheral blood-macrophage-conditioned medium (PB-MCM)-induced signaling in
chondrocytes. Chondrocytes were untreated (CL) or stimulated with PB-MCM for the indicated periods (t). The results are the mean ± SEM of
three to four separate experiments and show the effects of IL-1ra on PB-MCM-induced JNK and Akt phosphorylation (A, t = 10 min) and NF-B
activation (B, t = 1 hour), respectively. Before culturing under control conditions (CL) or stimulation with PB-MCM, the PB-MCM and chondrocytes
were preincubated with 1 × PBS or IL-1ra for 2 hours. *P < 0.05 versus CL. #P < 0.05 versus PBS-treated cells under PB-MCM stimulation.
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3. Macrophage-induced uPA expression in chondro-
cytes is mediated through JNK and Akt phosphorylation,
and NF-B activation; and
4. Lower shear stresses attenuate peripheral blood
macrophage-induced uPA expression.
uPA is a serine protease that converts plasminogen to
plasmin. Plasmin can then degrade proteoglycans and
transform MMPs into their active forms. The uPA itself
also has a direct role in the degradation of ECM pro-
teins [7]. The PA/plasmin system has a broad spectrum
of activity. In human OA and animal models of OA,
where enhanced bone remodeling may trigger cartilage
damage, uPA/plasmin is upregulated [27]. Other reports
also indicated a higher expression and activity of uPA in
arthritis groups compared with normal controls [28,29].
The increased levels of uPA in OA joints suggest that
they play a role in this disease. It has been demonstrated
that the transcript levels of uPA increase significantly
during the early and medium stages of OA [30]. The
ability of macrophages to stimulate uPA gene expression
in chondrocytes may, at least in part, lead to the eleva-
tion of uPA in the synovial fluid during OA progression.
The mechanism by which macrophages regulate uPA
gene expression in chondrocytes, however, remains
unclear.
In our present study, we investigated the molecular
mechanisms by which macrophages stimulate uPA
expression in human chondrocytes. We provide several
lines of evidence from our current data that macro-
phage-induced uPA expression in chondrocytes is
mediated via NF-B. First, we found that PB-MCM sti-
mulates uPA expression and production by human
chondrocytes in an in vitro culture system. Second, TF
ELISA and ChIP assays demonstrated an increase in
Figure 7 Exposure of chondrocytes to lower shear stress inhibits peripheral blood-macrophage-conditioned medium (PB-MCM)-
induced urokinase-type PA (uPA) expression. Chondrocytes were kept as controls (CL), or subjected to different levels of shear stress with
PB-MCM stimulation. Static chondrocytes were stimulated with PB-MCM without shearing (static). All bar graphs represent fold differences
compared with control chondrocytes (CL), mean ± SEM. *P < 0.05 versus CL cells. #P < 0.05 versus static chondrocytes with PB-MCM stimulation.
(A) uPA mRNA levels determined by real-time PCR analysis. The mRNA data are presented as the fold changes in fluorescent intensities
compared with CL cells normalized to the 18S rRNA levels. (B) The phosphorylation of JNK and Akt after 10 minutes of PB-MCM stimulation was
determined by Western blotting. The results are mean ± SEM. All bar graphs represent folds of CL and are normalized to total JNK or Akt. (C)
NF-B p65 binding to the uPA promoter after 1 hour of PB-MCM stimulation was analyzed by ChIP assay by using a p65 antibody. All bar
graphs represent folds of CL and are normalized based on the input DNA.
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NF-B binding to the uPA gene promoter in chondro-
cytes. Third, the inhibition of NF-B activation in chon-
drocytes by pretreatment with JNK and Akt inhibitors,
transfection with specific siRNAs of JNK, or the expres-
sion of a dominant-negative mutant of Akt, abolishes
macrophage-induced uPA expression.
The results of our present study also demonstrate for
the first time that macrophages not only promote the
secretion of uPA, but also induce their gene expression
in cultured human chondrocytes, and that macrophage-
induced uPA expression occurs at the transcriptional
level. Analysis of human uPA promoter activity with dif-
ferent plasmid constructs further revealed that NF-B is
the major cis element for PB-MCM responsiveness via
JNK and Akt phosphorylation. It was reported pre-
viously that the expression of inflammatory genes in
chondrocytes is controlled by different signaling path-
ways, which leads to activation of the MAPKs and PI3K,
and of the transcriptional regulator NF-B [31,32].
Based on our current results, we propose a possible
mechanism by which macrophages induce JNK and Akt
phosphorylation in chondrocytes, which in turn pro-
motes NF-B binding to the uPA promoter and its sub-
sequent transcriptional activation.
Cartilage destruction in arthritis is somehow affected
by interactions between chondrocytes and macrophages.
Chondrocytes increase their secretion of catabolic
enzyme activities after exposure to macrophages [2],
whereas the activation of MMP-9 produced by macro-
phages is dependent on chondrocyte-derived factors
[33]. It has been shown that synovial tissue from early
OA patients contains more macrophages, which may
suggest that inflammation is at higher levels during the
early phases of OA [34]. Macrophage derived-cytokines
might therefore play a crucial role in the onset and pro-
gression of OA. IL-1b and TNF-a are associated with
the development of early arthritis, whereas IL-1b main-
tains the inflammatory reaction in later stages [35]. It
has been suggested that, in the osteoarthritis synovium,
both inflammatory and destructive responses are depen-
dent largely on macrophages and that these effects are
cytokine-driven through a combination of IL-1 and
TNF-a [36]. IL-1b has also been reported to have syner-
gistic effects with other cytokines that regulate catabolic
gene expression in human chondrocytes [37,38]. IL-1b
has been considered the central mediator of cartilage
loss in OA by upregulating the extracellular proteolytic
enzymes in cartilage degradation, such as MMPs and
aggrecanases [39]. Additionally, it has been reported
that uPAR, which is involved in cartilage degradation by
serine proteinases and is upregulated in OA, is stimu-
lated on chondrocytes in a dose-dependent manner by
Figure 8 Effect of AMPK on peripheral blood-macrophage-conditioned medium (PB-MCM)-induced urokinase-type PA (uPA)
expression. All bar graphs represent folds of control chondrocytes (CL) and are normalized to 18S rRNA. The results are shown as mean ± SEM.
(A) Chondrocytes were kept as CL or stimulated with PB-MCM for 2 hours. Before being kept as CL or stimulated with PB-MCM, cells were
pretreated with 0.5 to 1 mM AICAR for 2 hours. *P < 0.05 versus CL chondrocytes. #P < 0.05 versus DMSO-treated chondrocytes (vehicle control)
with PB-MCM stimulation. (B) Chondrocytes were kept as CL, or subjected to 2 dyn/cm2 of shear stress (SS) with PB-MCM stimulation. Cells were
treated with 10 mM compound C or transfected with si-CL or si-AMPK. Static chondrocytes were stimulated with PB-MCM without shearing
(static). *P < 0.05 versus CL, vesicle control (SS + DMSO), or control siRNA-transfected (SS + si-CL) cells with PB-MCM stimulation. #P < 0.05 versus
compound C-treated (SS + com C) or AMPK siRNA-transfected (SS + si-AMPK) cells with PB-MCM stimulation.
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IL-1b [40]. Although the effect of IL-1b on chondrocyte
has been extensively studied, and inflammatory macro-
phages and the mediators they release have been impli-
cated in the pathology of OA, the detailed mechanism
of macrophage-induced uPA expression in human chon-
drocytes remains unclear. The increases in uPA expres-
sion in chondrocytes induced by PB-MCM suggest that
macrophages may release soluble mediators to exert
paracrine effects on chondrocytes and thereby induce
uPA expression.
Our current data further indicate that TNF-a is not a
major mediator of uPA expression in chondrocytes. The
inhibitory effects of IL-1ra on the PB-MCM-induced
activation of NF-B and uPA expression in chondro-
cytes suggest that the effects of PB-MCM are mediated
by the binding of IL-1b to their cognate receptors in
these cells. Our results propose a possible signal-trans-
duction pathway in chondrocytes in which macrophages
release IL-1b, which induces JNK and Akt phosphoryla-
tion, and NF-kB activation, thus resulting in uPA tran-
scriptional activation, expression, and secretion.
Previous studies have shown that IL-1b is responsible
for the inflammatory gene upregulation in human chon-
drocytes through activation of the JNK or Akt, and NF-kB
signaling pathways [41,42]. Here we showed that IL-1b is
the critical factor in PB-MCM-induced uPA expression of
chondrocytes through activation of JNK and Akt simulta-
neously. The present study demonstrated that AP-1 is also
involved, but plays lesser roles, in PB-MCM-induced
uPA expression (Figure 3). Therefore, our results suggest
that IL-1b-induced signaling may be a major factor in
PB-MCM-induced uPA expression and that other signal-
ing pathways induced by macrophages may also have
minor roles in regulating uPA expression in chondrocytes.
Mechanical stimulation is well recognized as having
regulatory effects on different cell types, including
tumor cells [17], chondrocytes [14], and vascular cells
[19] derived from tissues normally exposed to mechani-
cal forces. It has been reported that physiologicl levels
of shear stress play important roles in vascular endothe-
lial function and gene expression. Higher levels of shear
stress (>15 dyne/cm2) induce endothelial quiescence and
atheroprotective gene expression, whereas lower shear
stress (<4 dyne/cm2) stimulates an atherogenic pheno-
type [43,44]. Previous studies also demonstrated that
high shear stress (20 dyn/cm2) significantly inhibits
proinflammatory factor- or smooth muscle cell-induced
expression of inflammatory genes in endothelial cells
[19,45]. The pressure that is applied to joints comprises
a complex combination of strain, shear stress, and com-
pressive forces [46]. However, whereas compressive or
hydrostatic forces have been studied and shown to be
beneficial at specific frequencies and levels, the effects
of shear stress on chondrocytes remain controversial.
In addition, exercise has been shown to improve pain
and function in OA and is recommended by the
Osteoarthritis Research Society International (OARSI)
for the management of hip and knee OA [47]. However,
to date, very little research has been conducted to inves-
tigate whether physiological shear stress can also be
used to prevent the onset of OA. Fluid shear stress has
been shown to activate proinflammatory genes such as
cyclooxygenase-2, prostaglandins (PGs), and IL-6
[24,32]. It has been demonstrated that exposure of
human chondrocytes to high shear stress, Toll-like
receptor 4 (TLR4), and caveolin-1 is upregulated by
sequential expression of microsomal PGE synthase-1
and L-PGD synthase. TLR4 and caveolin-1 exert antago-
nistic effects on IL-6 synthesis; and further regulate the
activity of ERK1/2, PI3K, protein kinase A, and NF-B-
dependent IL-6 expression in sheared chondrocytes [48].
In addition, another study has reported that high fluid
shear stress induces IL-1b and 15-deoxy-Δ12,14-prosta-
glandin J2 synthesis, which antagonistically regulate
MMP-9 expression via PI3K-, ERK1/2-, -PPARg-, and
JNK-dependent NF-B-activating pathways in human
chondrocytes at short and long shear-exposure times
[49]. Previous studies have largely focused on shear
stress-induced NF-B activation and the following
effects on chondrocyte catabolic gene expression, but
the modulating effect of shear stress on inflammatory
stimuli-induced uPA expression in chondrocytes has not
been elucidated.
Our present study reveals for the first time that
macrophage-induced uPA upregulation is inhibited in
chondrocytes subjected to lower levels of shear stress.
Exposure of chondrocytes to shear stress of 2 dyn/cm2,
but not 20 dyn/cm2, significantly inhibits peripheral
blood macrophage-induced signal transduction and uPA
expression. Hence, lower shear stress may exert chon-
droprotective effects by suppressing macrophage-
induced uPA expression.
AMPK has been recognized to exert antiinflammatory
effects in multiple tissues [50]. It is activated in response
to physiological stimuli such as nutrient deprivation,
hypoxia, or shear stress [51,52]. Some evidence supports
a role of AMPK in the regulating of cell function in
chondrocytes. AMPK activators inhibited IL-1b- and
TNF-a-induced expression of procatabolic genes in
chondrocytes [23]. In addition, inhibition of AMPK
increases chondrocyte sensitivity to the induction of
apoptosis [53]. In this study, administration of AICAR
significantly suppressed PB-MCM-induced uPA expres-
sion. Exposure of chondrocytes to shear stress at 2 dyn/
cm2 inhibited PB-MCM-induced uPA expression, and
this shear effect was blocked by treatment of compound
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C and transfection of AMPK siRNA. Thus, our findings
indicate that AMPK activity may contribute to shear-
mediated antiinflammatory effects in human chondrocytes.
Conclusions
In summary, we here demonstrate for the first time that
different levels of shear stress have regulatory effects on
inflammatory stimuli-induced gene expression in chon-
drocytes. Our analyses have also identified a unique
molecular mechanism of macrophage-induced JNK and
Akt phosphorylation, NF-B activation, and uPA expres-
sion in chondrocytes. These findings provide a molecular
basis for the mechanisms underlying the protective func-
tion of shear stress against uPA induction. Because macro-
phage infiltration and uPA upregulation are principal
features of early-stage OA, our current data have potential
relevance for cartilage tissue engineering and future thera-
peutic interventions in arthritis patients.
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